Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07065383

Rebalancing the Fat Content of the Heart and Muscles

Intramyocellular Lipid Compartments After Glucagon-like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes - Rebalancing the Fat Content of the Heart and Muscles

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Traditional diabetes therapies focus on improving blood sugar control. However, many studies show that this may not be enough. New treatments focusing on weight loss have heralded better results. One of these treatments is Semaglutide and the investigators wish to examine its effects further in this study. The investigators propose to investigate what happens to the fat inside the heart and the leg muscles.

Detailed description

Traditionally, diabetes therapies focus on improving glycaemic control. However, decades of well conducted clinical trials showed that glycaemic control alone has failed to reduce both all-cause and cardiovascular mortality in diabetes patients. The new diabetes treatment strategies of combining glucose control with weight reduction have heralded better cardiovascular outcomes, however their follow-up has been relatively short-term. The investigators propose to explore the effects of semaglutide administration plus dietary counselling and physical activity encouragement versus a more intensive strategy of semaglutide administration plus a personalised and supervised program of resistance and endurance exercise training.

Conditions

Interventions

TypeNameDescription
DRUGSemaglutide administration plus dietary counselling and physical activity encouragementSemaglutide administration plus dietary counselling and physical activity encouragement
DRUGSemaglutide plus a personalised and supervised program of resistance and endurance trainingSemaglutide administration plus a personalised and supervised program of resistance and endurance training.

Timeline

Start date
2025-08-01
Primary completion
2028-07-31
Completion
2028-07-31
First posted
2025-07-15
Last updated
2025-07-15

Source: ClinicalTrials.gov record NCT07065383. Inclusion in this directory is not an endorsement.